These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6182782)

  • 81. Systemic autoimmune disease and Raynaud's phenomenon: a common, immunologically mediated, vascular basis?
    Kallenberg CG; Wouda AA; The TH
    Neth J Med; 1984; 27(9):322-6. PubMed ID: 6334812
    [No Abstract]   [Full Text] [Related]  

  • 82. A comparative study of glucose oxidase versus FITC-labeled antibody techniques for the detection of antinuclear antibodies.
    McFadden N; Chen Z; Ainsworth SK
    Diagn Immunol; 1984; 2(2):128-31. PubMed ID: 6437730
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Anti-dsDNA antibodies in sera of patients without systemic lupus erythematosus.
    Wollina U
    Allerg Immunol (Leipz); 1984; 30(4):222-4. PubMed ID: 6240935
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical significance of antinuclear antibodies.
    Rothfield NF
    J Med Assoc Ga; 1967 Dec; 56(12):491-4. PubMed ID: 4866469
    [No Abstract]   [Full Text] [Related]  

  • 85. Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease.
    Parker MD
    J Lab Clin Med; 1973 Nov; 82(5):769-75. PubMed ID: 4583583
    [No Abstract]   [Full Text] [Related]  

  • 86. [Determination of anti dsDNA antibodies by immunofluorescence using Crithidia luciliae. I--Diagnostic and prognostic value in systemic lupus erythematosus. Comparison with the Farr radioimmunoassay].
    Borda-Iriarte O; Meyer O; Cyna J; Haïm T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1984 Apr; 51(4):185-91. PubMed ID: 6374861
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Antinuclear and perinuclear atibodies in rheumatology. Immunofluorescence studies].
    Marmont A; Damasio E
    G Mal Infett Parassit; 1968 Jan; 20(1):124-32. PubMed ID: 4880275
    [No Abstract]   [Full Text] [Related]  

  • 88. Prospects and problems in the definition and standardization of immunofluorescence. I. Present levels of reproducibility and disease specificity of antinuclear antibody tests.
    Beutner EH; Krasny S; Kumar V; Taylor R; Chorzelski TP
    Ann N Y Acad Sci; 1983; 420():28-54. PubMed ID: 6372596
    [No Abstract]   [Full Text] [Related]  

  • 89. Rheumatic disease sera reactive with capillaries in the mouse kidney.
    Tan EM; Pearson CM
    Arthritis Rheum; 1972; 15(1):23-8. PubMed ID: 4551052
    [No Abstract]   [Full Text] [Related]  

  • 90. [DNA antibody determination in diffuse connective-tissue disease (author's transl)].
    Kerl H; Sandhofer M; Klein G; Altmann H
    Dtsch Med Wochenschr; 1974 Aug; 99(32):1626-7. PubMed ID: 4602107
    [No Abstract]   [Full Text] [Related]  

  • 91. Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors.
    Rekvig OP; Moens U; Sundsfjord A; Bredholt G; Osei A; Haaheim H; Traavik T; Arnesen E; Haga HJ
    J Clin Invest; 1997 Apr; 99(8):2045-54. PubMed ID: 9109450
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Characterisation of nucleolar proteins as autoantigens using human autoimmune sera.
    Pfeifle J; Anderer FA; Franke M
    Ann Rheum Dis; 1986 Dec; 45(12):978-86. PubMed ID: 3545105
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Diagnosis of systemic lupus erythematosus semiquantitative immunofluorescent method of LE factor determination in frozen and paraffin sections.
    Zeromski J; Jaźbor A
    Pol Med J; 1969; 8(6):1282-7. PubMed ID: 4189983
    [No Abstract]   [Full Text] [Related]  

  • 94. Aggravation of turpentine-induced pleurisy in rats by "homogeneous" and "speckled" antinuclear antibodies.
    Hughes P; Rowell NR
    J Pathol; 1970 Jun; 101(2):141-55. PubMed ID: 4097591
    [No Abstract]   [Full Text] [Related]  

  • 95. A novel antinuclear antibody associated with a lupus-like paraneoplastic syndrome.
    Freundlich B; Makover D; Maul GG
    Ann Intern Med; 1988 Aug; 109(4):295-7. PubMed ID: 3293493
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Antinuclear autoantibodies of IgD class. An analysis of 82 patients.
    Schmidt K; Mueller-Eckhardt C
    Z Immunitatsforsch Exp Klin Immunol; 1973 Sep; 145(5):385-91. PubMed ID: 4282956
    [No Abstract]   [Full Text] [Related]  

  • 97. Diagnostic tests for systemic lupus erythematosus.
    Mani RM; Trikannad VS; Batlivala PM; Krishnaswamy PR
    J Assoc Physicians India; 1980 Nov; 28(11):451-5. PubMed ID: 6163759
    [No Abstract]   [Full Text] [Related]  

  • 98. Antinuclear antibodies. Clinical significance of titers and fluorescence patterns.
    Husain M; Neff J; Daily E; Townsend J; Lucas F
    Am J Clin Pathol; 1974 Jan; 61(1):59-65. PubMed ID: 4128966
    [No Abstract]   [Full Text] [Related]  

  • 99. A modified technique of preparing mouse-liver nuclei for the detection of antinuclear antibodies (ANA) by immunofluorescence.
    Yantorno C; Riera CM; Risenberg A; Strussberg A
    J Immunol Methods; 1974 Aug; 5(3):253-7. PubMed ID: 4610055
    [No Abstract]   [Full Text] [Related]  

  • 100. [Antinuclear factors. Method of demonstration with immunofluorescence].
    Gheorghiu M; Purice S
    Med Interna (Bucur); 1970 Apr; 22(4):433-6. PubMed ID: 4911487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.